(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SOLAVAX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SOLAVAX

ST13

US500000088846226

Class

5

Filing

88846226

Registration

6890077

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

11/01/2022

Trademark type

Word

Nice classes

5

Filing date

03/24/2020

Registration date

11/01/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/01/2022

Last transaction

11/01/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/08/2022

First use in commerce

09/08/2022

Drawing code

4

Owner type

03

Owner location

Fort Collins, CO, US

Examiner

AWRICH, ELLEN

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

C. F. (pessoa física)

Representatives

Sabrina C. Stavish SHERIDAN ROSS P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

vaccines

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/01/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

11/01/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/27/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/26/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/23/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/23/2022

IUAF

USE AMENDMENT FILED

09/12/2022

EISU

TEAS STATEMENT OF USE RECEIVED

09/12/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/03/2022

EX3G

SOU EXTENSION 3 GRANTED

03/01/2022

EXT3

SOU EXTENSION 3 FILED

03/01/2022

EEXT

SOU TEAS EXTENSION RECEIVED

03/01/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/02/2021

EX2G

SOU EXTENSION 2 GRANTED

08/31/2021

EXT2

SOU EXTENSION 2 FILED

08/31/2021

EEXT

SOU TEAS EXTENSION RECEIVED

08/31/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/13/2021

EX1G

SOU EXTENSION 1 GRANTED

02/11/2021

EXT1

SOU EXTENSION 1 FILED

02/11/2021

EEXT

SOU TEAS EXTENSION RECEIVED

02/11/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/15/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/21/2020

PUBO

PUBLISHED FOR OPPOSITION

07/21/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/01/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/15/2020

DOCK

ASSIGNED TO EXAMINER

06/15/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/29/2020

NWAP

NEW APPLICATION ENTERED

03/27/2020

Continuous trademark protection

Get notified about every new filing that threatens SOLAVAX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.